We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cellular Biomedicine Group Inc | NASDAQ:CBMG | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.74 | 19.74 | 19.80 | 0 | 01:00:00 |
Rule 13d-1(b)
|
|
T
|
Rule 13d-1(c)
|
Rule 13d-1(d)
|
Cusip No.
276050101
|
13G
|
Page 2 of 5 Pages
|
Cusip No.
276050101
|
13G
|
Page 3 of 5 Pages
|
Item 1(a)
|
Name of Issuer
|
Cellular Biomedicine Group, Inc.
|
|
Item 1(b)
|
Address of Issuer’s Principal Executive Offices
|
530 University Avenue, #17, Palo Alto, California 94301
|
|
Item 2(a)
|
Name of Person Filing
|
Item 2(b)
|
Address of Principal Business Office
|
Item 2(c)
|
Citizenship
|
Item 2(d)
|
Title of Class of Securities
|
Item 2(e)
|
CUSIP Number
|
Item 3
|
If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
|
(a)
|
Broker or dealer registered under Section 15 of the Exchange Act;
|
(b)
|
Bank as defined in Section 3(a)(6) of the Exchange Act;
|
(c)
|
Insurance company as defined in Section 3(a)(19) of the Exchange Act;
|
(d)
|
Investment company registered under Section 8 of the Investment Company Act;
|
(e)
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
|
Cusip No.
276050101
|
13G
|
Page 4 of 5 Pages
|
(f)
|
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
|
(g)
|
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
|
(h)
|
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
|
(i)
|
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
|
(j)
|
Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
|
Item 4
|
Ownership
|
(a)
|
Mission Right beneficially owns 746,268
shares of Common Stock.
|
||
(b) | The number of shares Mission Right beneficially owns constitutes approximately 8.2% of the Common Stock outstanding. | ||
(c)
|
Number of shares as to which such person has:
|
||
(i)
|
sole power to vote or to direct the vote: 746,268
|
||
(ii)
|
shared power to vote or to direct the vote: 0
|
||
(iii)
|
sole power to dispose or to direct the disposition of: 746,268
|
||
(iv)
|
shared power to dispose or to direct the disposition of: 0
|
Item 5
|
Ownership of Five Percent or Less of a Class
|
Cusip No.
276050101
|
13G
|
Page 5 of 5 Pages
|
Item 6 | Ownership of More than Five Percent on Behalf of Another Person |
Item 7 | Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company |
Item 8 | Identification and Classification of Members of the Group |
Item 9 | Notice of Dissolution of Group |
Item 10 | Certification |
By:
|
s
Chan Boon Ho Peter
|
Name:
Chan Boon Ho Peter
|
|
Title: Director
|
1 Year Cellular Biomedicine Chart |
1 Month Cellular Biomedicine Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions